TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.72%)
As of: Sep 9, 2026 · 2:01 PM EDT

TAO Synergies (TAOX) Market Capitalization (2020 - 2026)

TAO Synergies' (TAOX) quarterly Market Capitalization came in at $27.9 million in Q2 2026, up 126.87% on a YoY basis from $12.3 million in Q2 2025, and down 34.44% quarter-over-quarter from $42.5 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Market Capitalization (2020 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Market Capitalization for 7 consecutive years, with $27.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Market Capitalization rose 126.87% year-over-year to $27.9 million; the trailing twelve-month figure through Jun 2026 stood at $27.9 million (up 126.87% YoY), and the FY2025 full-year result was $12.1 million, up 157.88% from the prior year.
  • Market Capitalization fell to $27.9 million in Q2 2026 per TAOX's latest filing, from $42.5 million in the prior quarter.
  • Across five years, Market Capitalization topped out at $1.3 billion in Q1 2022 and bottomed at $3.4 million in Q1 2025.
  • Historically, Market Capitalization has averaged $233.7 million across 5 years, with a median of $35.2 million in 2026.
  • The sharpest annual moves came in 2024 and 2026: Market Capitalization plunged 96.99% in 2024, then jumped 1164.07% in 2026.
  • Over 5 years, Market Capitalization stood at $210.7 million in 2022, then sank by 62.4% to $79.2 million in 2023, then sank by 94.06% to $4.7 million in 2024, then surged by 157.88% to $12.1 million in 2025, then surged by 129.52% to $27.9 million in 2026.
  • According to Business Quant data, Market Capitalization over the past three periods registered $27.9 million, $42.5 million, and $12.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.98 Bn 196.99 Bn 7.24 Bn
2 Gilead Sciences 181.24 Bn 178.06 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.38 Bn 124.53 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.97 Bn 74.97 Bn 3.93 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn
6 Moderna 54.80 Bn 49.67 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.09 Bn 30.78 Bn 992.69 Mn
8 Biogen 31.34 Bn 30.05 Bn 1.96 Bn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.87 Mn
Mar 31, 2026 42.52 Mn
Dec 31, 2025 12.14 Mn
Sep 30, 2025 16.70 Mn
Jun 30, 2025 12.29 Mn
Mar 31, 2025 3.36 Mn
Dec 31, 2024 4.71 Mn
Sep 30, 2024 4.09 Mn
Jun 30, 2024 5.14 Mn
Mar 31, 2024 5.10 Mn
Dec 31, 2023 79.23 Mn
Sep 30, 2023 117.73 Mn
Jun 30, 2023 170.87 Mn
Mar 31, 2023 147.20 Mn
Dec 31, 2022 210.74 Mn
Sep 30, 2022 1.15 Bn
Jun 30, 2022 883.64 Mn
Mar 31, 2022 1.32 Bn
Dec 31, 2021 1.07 Bn
Sep 30, 2021 1.53 Bn